Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy
Why the study?
Does gadolinium-enhanced CMR predict the response in LV function and remodeling in heart failure patients treated with beta-blockers?
Population
Heart failure patients treated with beta-blockers
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
May aid beta-blocker response prediction in HF via CMR; leaves open whether imaging should guide therapy pending randomized validation.
Key Points
- The aim is to investigate how gadolinium-enhanced cardiovascular magnetic resonance (CMR) predicts myocardial function and structural changes in heart failure patients on beta-blockers.
- Examined heart failure patients undergoing β-blocker therapy.
- Used gadolinium-enhanced cardiovascular magnetic resonance to evaluate left ventricular (LV) functionality.
- Analyzed data for predictive relationships between CMR results and functional response.
- Gadolinium CMR effectively predicts improvements in left ventricular function.
- Patients showing enhancement had improved myocardial remodeling post-beta-blocker therapy.
Structured PICO
Does gadolinium-enhanced CMR predict the response in LV function and remodeling in heart failure patients treated with beta-blockers?
P
Population
Heart failure patients treated with beta-blockers
I
Intervention
Gadolinium-enhanced Cardiovascular Magnetic Resonance (CMR)
O
Outcome
Response in LV function and remodelingsurrogate
Gadolinium-enhanced CMR can serve as a predictive tool for assessing potential improvements in LV function and remodeling in heart failure patients initiating beta-blocker therapy.
Cite This Study
Bello et al. (2003) studied this question.